Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
Media and Investors Resources
Press Release, 13 August 2026
Kuros Biosciences delivers 45% H1 2026 year-over-year sales growth and increases overall profitability
Press Release, 17 June 2026
Kuros Biosciences to showcase MagnetOs™ commercial momentum and plan for scalable quality growth at Capital Markets Day in Zürich
Press Release, 7 May 2026
Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth
Press Release, 15 April 2026
Annual General Meeting of Kuros Biosciences approves all resolutions
Press Release, 14 April 2026
Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026
Press Release, 10 March 2026
Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025
media-investors